Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes

被引:95
|
作者
Emoto, M
Kanda, H
Shoji, T
Kawagishi, T
Komatsu, M
Mori, K
Tahara, H
Ishimura, E
Inaba, M
Okuno, Y
Nishizawa, Y
机构
[1] Osaka City Univ, Sch Med, Dept Internal Med 2, Abeno Ku, Osaka, Japan
[2] Osaka City Univ, Sch Med, Inst Geriatr & Med Sci, Dept Cardiovasc Med, Osaka, Japan
关键词
D O I
10.2337/diacare.24.3.533
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To assess the impacts of insulin resistance and renal function on plasma total homocysteine (tHey) levels in patients with type 2 diabetes with a wide range of nephropathy. RESEARCH DESIGN AND METHODS - Plasma tHey levels were measures using the enzyme immunoassay method in 75 patients with type 2 diabetes and compared with those in 54 healthy control subjects. Insulin sensitivity indexes were assessed in patients with type 2 diabetes by hyperinsulinemic-euglycemic clamp using artificial pancreas. RESULTS - Plasma tHey levels and their log-transformed values (log tHey) were significantly higher in all patients with diabetes than in control subjects (tHey, 12.0 +/- 0.7 [SE] vs. 8.7 +/- 0.3 mu mol/l, P < 0.0001; log tHey, 1.040 +/- 0.021 vs. 0.920 +/- 0.016 <mu>mol/l, P < 0.0001). Plasma tHey levels in patients with diabetes were significantly increased according to degree of nephropathy (P < 0.0001). On simple regression analyses, log tHey correlated with insulin sensitivity. indexes (r = -0.319, P = 0.005) as well as creatinine clearance (r = 0.634. P < 0.0001) in all patients with diabetes. Multiple regression analyses showed that insulin sensitivity indexes (<beta> = -0.245) as well as creatinine clearance were independent contributors to log tHey in all patients with diabetes (R-2 = 0.750, P < 0.0001). For the 59 patients with diabetes with creatinine clearance >60 ml/min, insulin sensitivity indexes were also shown to be a significant contributor to log tHey (P = -0.438, R-2 = 0.561, P < 0.001). CONCLUSION - Insulin resistance and renal function are independent determinants of tHey levels in patients with type 2 diabetes.
引用
收藏
页码:533 / 538
页数:6
相关论文
共 50 条
  • [41] Insulin Resistance in Prevalent Coronary Artery Disease and Overt Nephropathy in Type 1 Diabetes
    Williams, Katherine V.
    Orchard, Trevor J.
    DIABETES, 2017, 66 : A651 - A651
  • [42] Albuminuria and insulin resistance measures in type 2 diabetes
    Barlovic, Drazenka Pongrac
    Zaletel, Jelka
    Prezelj, Janez
    DIABETES, 2008, 57 : A206 - A206
  • [43] Visceral Adiposity, Insulin Resistance, and Type 2 Diabetes
    Griffith, Michelle L.
    Younk, Lisa M.
    Davis, Stephen N.
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2010, 4 (03) : 230 - 243
  • [44] The role of PPAR γ in insulin resistance and type 2 diabetes
    Hara, K
    Tobe, K
    Okada, T
    Mori, Y
    Yasuda, K
    Kadowaki, H
    Hagura, R
    Akanuma, Y
    Ito, C
    Kadowaki, T
    DIABETES, 2000, 49 : A204 - A204
  • [45] Innate immunity, insulin resistance and type 2 diabetes
    Fernandez-Real, J. M.
    Pickup, J. C.
    DIABETOLOGIA, 2012, 55 (02) : 273 - 278
  • [46] Insulin action and resistance in obesity and type 2 diabetes
    Czech, Michael P.
    NATURE MEDICINE, 2017, 23 (07) : 804 - 814
  • [47] Endothelial dysfunction in insulin resistance and type 2 diabetes
    Jansson, P.-A.
    JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) : 173 - 183
  • [48] Vitamin D, Insulin Resistance, and Type 2 Diabetes
    Song Y.
    Manson J.E.
    Current Cardiovascular Risk Reports, 2010, 4 (1) : 40 - 47
  • [49] Is insulin resistance the principal cause of type 2 diabetes?
    Gerich, JE
    DIABETES OBESITY & METABOLISM, 1999, 1 (05): : 257 - 263
  • [50] Dapagliflozin and Insulin Resistance in Patients with Type 2 Diabetes
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A304 - A305